Skip to main content

Month: January 2021

AS Tallinna Vesi tootmistulemused 2020. aastal

2020.aasta oli koroonaviiruse leviku tõttu erakorraline aasta, mil Tallinna Vesi tegi suuri muudatusi tööprotsessides, et tagada töötajate ohutus ja elutähtsa teenuse kvaliteetne osutamine. Tänu sellele õnnestus meil hoida kõrgel tasemel nii joogi- kui ka heitvee kvaliteet ja kasvatada võrgu töökindlust. Mitmed kvaliteedinäitajad saavutasid lõppenud aastal rekordtaseme.Tagasime kvaliteetse joogivee ja puhta heitveeKui aasta varem vastas tarbija kraanist võetud kvaliteediproovidest nõuetele 99,04 %, siis 2020. aastal jõudis see kvaliteedinäitaja 99,71 % tasemele. See tähendab, et täiendavad veevõrgu arendus- ja hooldustööd, mida hakkasime tegema pärast veeproovide senisest tundlikuma analüüsimeetodi kasutuselevõttu, on andnud häid tulemusi.Selleks, et efektiivselt toimida ja kasutada vett säästlikult, oleme teinud suuri pingutusi veekadude...

Continue reading

Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock

CAMBRIDGE, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that it has priced an underwritten public offering of 4,000,000 shares of its common stock at a public offering price of $11.00 per share, for total gross proceeds of $44.0 million, before deducting underwriting discounts and commissions and offering expenses payable by Fulcrum. All of the shares in the offering are being sold by Fulcrum. In addition, Fulcrum has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of its common stock at the public offering price, less the underwriting discount and commissions. The offering is expected to close on January 22, 2021,...

Continue reading

TCR² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock

CAMBRIDGE, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR) (“TCR2” or the “Company”), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced the pricing of an underwritten public offering of 4,590,164 shares of its common stock at a public offering price of $30.50 per share. TCR2 also granted the underwriters a 30-day option to purchase up to an additional 688,524 shares of common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by the Company, are expected to be approximately $140.0 million, excluding any exercise of the underwriters’ option to purchase additional...

Continue reading

Legato Merger Corp. Announces Pricing of Upsized $205,000,000 Initial Public Offering

New York, NY, Jan. 19, 2021 (GLOBE NEWSWIRE) — Legato Merger Corp.(NASDAQ: LEGOU) (the “Company”) announced today that it priced its upsized initial public offering of 20,500,000 units at $10.00 per unit.  The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “LEGOU” beginning January 20, 2021.  Each unit consists of one share of common stock and one warrant to purchase one share of common stock at a price of $11.50 per share, subject to adjustment. Once the securities comprising the units begin separate trading, the common stock and warrants are expected to be listed on Nasdaq under the symbols “LEGO” and “LEGOW,” respectively.EarlyBirdCapital, Inc. is acting as the sole book running manager for the offering. I-Bankers Securities, Inc. is acting as co-manager.  The Company has granted...

Continue reading

Document Security Systems, Inc. Prices $24.0 Million Upsized Public Offering of Common Stock

ROCHESTER, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) — Document Security Systems, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced the pricing of an upsized underwritten public offering with gross proceeds to the Company expected to be approximately $24.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.The public offering equates to 6,666,666 shares of the Company’s common stock at a price of $3.60 per share. The Company intends to use the net proceeds from this offering, together with their existing cash, to fund the development and growth of new business lines, acquisition...

Continue reading

CORRECTION – Uniti Group Inc. Announces Pricing and Upsizing of Senior Notes Offering

LITTLE ROCK, Ark., Jan. 19, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Uniti Group Inc. (Nasdaq: UNIT) please note that at the end of the first paragraph of the release, the year should read 2021, not 2020 as previously stated. The corrected release follows:Uniti Group Inc. (the “Company”, “Uniti”, or “we”) (Nasdaq: UNIT) today announced that its subsidiaries, Uniti Group LP, Uniti Group Finance 2019 Inc. and CSL Capital, LLC (together, the “Issuers”), have priced their offering of $1,110 million aggregate principal amount of 6.50% senior notes due 2029 (the “new notes”), which represents an increase of $360 million from the previously announced offering size of $750 million. The new notes will be issued at an issue price of 100%. The new notes will be guaranteed on a senior unsecured basis...

Continue reading

Centerra Gold Completes Sale of 50% Interest in the Greenstone Gold Mines Partnership

TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra”) (TSX: CG) announced today the completion of the previously announced sale of Centerra’s 50% interest in the Greenstone Gold Mines Partnership (“GGM”) to an affiliate of the Orion Mine Finance Group.Centerra received an up-front cash payment of approximately U.S.$210 million (including adjustments) and is entitled to receive further contingent payments of up to approximately U.S.$75 million (assuming a U.S.$1,500 gold price) upon GGM’s Hardrock Project meeting certain construction and / or production milestones. Further details can be found in Centerra’s December 15, 2020 news release.Cormark Securities Inc. acted as financial advisor to Centerra and Stikeman Elliott LLP as legal advisor.Cautionary Note Regarding Forward-Looking InformationThis news release...

Continue reading

Uniti Group Inc. Announces Amendments to its Previously Announced Cash Tender Offer and Solicitation of Consents Relating to its 8.25% Senior Notes due 2023

LITTLE ROCK, Ark., Jan. 19, 2021 (GLOBE NEWSWIRE) — Uniti Group Inc. (the “Company” or “Uniti”) (Nasdaq: UNIT) today announced that its subsidiaries, Uniti Group LP, Uniti Group Finance 2019 Inc. and CSL Capital, LLC (collectively, the “Issuers” and, together with the Company, “us” or “we”), have amended the terms of the Issuers’ previously announced cash tender offer (the “Offer”) for the Issuers’ outstanding 8.25% Senior Notes due 2023 (the “Notes”) to remove the tender cap of $750 million (the “Aggregate Maximum Tender Cap”), which represented the maximum aggregate purchase price of the Notes to be accepted for purchase under the Offer. As a result, the Offer now extends to any and all Notes outstanding.Consistent with removing the Aggregate Maximum Tender Cap, the Issuers have amended the financing condition of the Offer to...

Continue reading

Amlan International任命 周皓Harold Zhou 担任中国区域运营总监

芝加哥, Jan. 20, 2021 (GLOBE NEWSWIRE) — Amlan International 是一家全球领先的矿物基饲料添加剂公司,致力于改善家禽和牲畜的肠道健康与饲养效率,最近该公司任命 周皓Harold ZHOU 担任中国区域运营总监。周皓常驻 Amlan 在中国深圳的销售办事处。在此职位中,周皓将致力于进一步扩大 Amlan 在中国的业务范围,同时制定实现长期客户价值和盈利能力的计划。他将协助实现 Amlan 的使命:将天然饲料添加剂解决方案带给中国市场内的养殖商和分销商。“Harold 擅长建立牢固的客户关系和成功实施业务战略,他所拥有的经验将助力 Amlan 进一步提升销售业绩,同时在中国提供更完善的客户服务,”Amlan International 公司的全球销售副总裁 Fred Kao 如此说道。“Harold 与 Amlan 共同肩负着为养殖商提供创新动物蛋白质解决方案和卓越客户服务的使命。我们很高兴他能成为团队的一员。”周皓拥有丰富的行业经验,从担任兽医帮助客户诊断和治疗牲畜疾病,再到就职技术服务和销售岗位,期间他开展了许多营销活动并与多家动物健康公司建立了重要的客户关系。周皓最近一份职务是在一家著名的全球谱系肉鸡育种公司担任中国销售总监,期间他制定了全国范围的销售战略,同时领导销售和技术团队为该地区的主要客户提供服务。此前,他在其他知名的动物保健公司担任销售和技术服务职务,制定销售战略并主持国家范围内的新动物保健产品推介。  周皓毕业于四川农业大学,获得兽医学学士学位和临床兽医学硕士学位。“Amlan 以其丰富的专业知识利用独家的专利矿物基技术,借此引领天然矿物基饲料添加剂解决方案的制定和推出,这些解决方案可增强动物健康和提升饲养效率,同时改善动物蛋白质的质量,”美国 Oil-Dri 公司总裁兼首席执行官 Dan Jaffee 如此说道。Jaffee 还曾担任 Amlan International 的总裁兼总经理。“我们很高兴...

Continue reading

Uniti Group Inc. Announces Pricing and Upsizing of Senior Notes Offering

LITTLE ROCK, Ark., Jan. 19, 2021 (GLOBE NEWSWIRE) — Uniti Group Inc. (the “Company”, “Uniti”, or “we”) (Nasdaq: UNIT) today announced that its subsidiaries, Uniti Group LP, Uniti Group Finance 2019 Inc. and CSL Capital, LLC (together, the “Issuers”), have priced their offering of $1,110 million aggregate principal amount of 6.50% senior notes due 2029 (the “new notes”), which represents an increase of $360 million from the previously announced offering size of $750 million. The new notes will be issued at an issue price of 100%. The new notes will be guaranteed on a senior unsecured basis by the Company and each of its subsidiaries (other than the Issuers) that guarantees indebtedness under the Company’s senior secured credit facilities and existing notes. The offering is expected to close on February 2, 2020.The Issuers intend...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.